Improving White Blood Cell Collection From Healthy Donors — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Improving White Blood Cell Collection From Healthy Donors — Stella

Home/Allogeneic Granulocyte Donation/

View on ClinicalTrials.gov

Recruiting

Back to Allogeneic Granulocyte Donation trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

National Institutes of Health Clinical Center, Bethesda, Maryland

Key details

Phase

Post-approval study

Sponsor

National Institutes of Health Clinical Center (CC)

Enrollment target

~1,000 participants

Started

December 2012

Primary completion

January 2032

Age range

18 Years – 75 Years

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.